Biolyt Legal
Legal · Document 02

Terms of Service

The terms under which Biolyt AI provides, and you may use, the Biolyt DeepAgent platform.

Last Updated March 1, 2026
Publisher Biolyt AI
Version 2026.03

These Terms of Service (“Terms”) govern your access to and use of the Biolyt DeepAgent platform operated by Biolyt AI (“Biolyt”, “we”, “us”) at biolytai.com. By creating an account or using the service, you agree to be bound by these Terms. If you do not agree, please discontinue use immediately.

Section 01
Acceptance of terms

By accessing or using the Biolyt DeepAgent platform, you represent that you are authorized to agree to these Terms on behalf of yourself or the organization you represent, and that you will comply with all applicable laws and regulations.

Section 02
Description of the service

Biolyt is an AI platform designed for professionals in the life-sciences sector. It provides conversational access to public and licensed datasets including, but not limited to, clinical trial registries, drug and pipeline data, regulatory filings, and tender intelligence. Responses are generated by large language models in combination with retrieval tools and code execution.

Important notice
Biolyt is an informational tool. Its output does not constitute medical, legal, investment, or regulatory advice, and should be independently verified before being used in any clinical, commercial, or regulatory decision.

Section 03
Eligibility & accounts

You must be at least sixteen years of age and have the legal capacity to enter into a binding agreement to use Biolyt. You are responsible for maintaining the confidentiality of your account credentials (including your Google OAuth session) and for all activity that occurs under your account. Notify us immediately at contact@biolytai.com if you suspect unauthorized access.

Section 04
Acceptable use

You agree not to:

Section 05
Data utilisation

Note
By using Biolyt, you acknowledge that we may use your interactions and submitted data to improve the platform’s functionality, quality, and safety — specifically to generate more accurate answers.

Aggregate prompt patterns and output quality signals inform our internal evaluation and tuning. We do not share your raw conversation data with third parties for marketing or advertising. See our Privacy Policy for full details.

Section 06
Intellectual property

The Biolyt platform, including its design, code, branding, and documentation, is owned by Biolyt AI and protected by applicable intellectual property laws. You retain ownership of the content you submit (prompts, files). You grant Biolyt a limited, worldwide, royalty-free licence to process that content solely for the purpose of operating and improving the service.

Outputs generated by the agent are provided to you for your internal use, subject to the restrictions in these Terms and the licence terms of the underlying data sources (such as ClinicalTrials.gov).

Section 07
Disclaimers

The service is provided on an “AS IS” and “AS AVAILABLE” basis without warranties of any kind, express or implied. Biolyt makes no warranty that the service will be uninterrupted, error-free, or that the information generated by the agent is accurate, complete, or fit for any particular purpose. Generative AI can produce inaccurate or hallucinated statements; always verify important information with authoritative sources.

Section 08
Limitation of liability

To the maximum extent permitted by law, Biolyt AI, its officers, employees, contractors, and partners shall not be liable for any indirect, incidental, special, consequential, or punitive damages — including but not limited to losses arising from clinical misinterpretation, hallucination, data inaccuracy, loss of profit, or business interruption — arising out of or in connection with your use of the service.

Section 09
Termination

We may suspend or terminate your access to Biolyt at any time, with or without notice, if we believe you have violated these Terms or if required by law. You may terminate your account at any time by contacting contact@biolytai.com. Upon termination, provisions relating to intellectual property, disclaimers, and limitation of liability shall survive.

Section 10
Changes to these terms

We may update these Terms from time to time. Material changes will be announced in-app or by email prior to taking effect. Your continued use of the service after the effective date of a revision constitutes acceptance of the revised Terms.

Section 11
Contact

Questions about these Terms? Email contact@biolytai.com or connect with us on LinkedIn.